Anya Biopharm Inc. (TPEX:7776)
Taiwan · Delayed Price · Currency is TWD 23.85
+0.05 (0.21%)
At close: Jun 12, 2026
Anya Biopharm Market Cap
Anya Biopharm has a market cap or net worth of 1.17 billion as of June 12, 2026. Its market cap has decreased by -29.12% in one year.
Market Cap
1.17B
Enterprise Value
803.82M
Revenue
16.27M
Ranking
n/a
PE Ratio
n/a
Stock Price
23.85
Market Cap Chart
Since October 25, 2024, Anya Biopharm's market cap has decreased from 2.85B to 1.17B, a decrease of -58.95%. That is a compound annual growth rate of -42.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 12, 2026 | 1.17B | -50.10% |
| Dec 31, 2025 | 2.35B | 26.96% |
| Dec 31, 2024 | 1.85B | -35.20% |
| Oct 25, 2024 | 2.85B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pharmasaga | 13.84B |
| TCM Biotech International | 9.06B |
| Taho Pharmaceuticals | 6.28B |
| Libo Pharma | 2.71B |
| Anbogen Therapeutics | 2.23B |
| TEH SENG Pharmaceutical Mfg. | 1.99B |
| Timing Pharmaceutial | 1.75B |
| Protect Animal Health | 1.69B |